{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:16:29Z","timestamp":1785860189494,"version":"3.56.0"},"reference-count":169,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The transgender population has been steadily increasing, with more individuals seeking gender-affirming care to align their physical characteristics with their gender identity. Despite advances in healthcare, transgender individuals face significant barriers to accessing culturally competent care, resulting in heightened cardiovascular risks and disparities. Cardiovascular disease prevalence among transgender individuals is influenced by a combination of physiological, psychological, and social factors, including the impacts of gender-affirming hormone therapy, surgical interventions, and minority stress. This review examines the cardiovascular risks associated with estrogen therapy in transfeminine individuals and testosterone therapy in transmasculine individuals, highlighting their effects on lipid profiles, thromboembolic risks, and metabolic parameters. Furthermore, it explores the implications of gender-affirming surgeries and the role of psychosocial stress in cardiovascular outcomes. Current evidence underscores the need for tailored risk assessment, proactive management strategies, and lifestyle interventions to optimize cardiovascular health in this population. Significant research gaps remain regarding the long-term cardiovascular effects of gender-affirming care. Large-scale, prospective studies and the development of transgender-specific cardiovascular care guidelines are crucial to address these gaps. This review advocates for a multidisciplinary, patient-centered approach to mitigate cardiovascular risks and improve outcomes for transgender individuals.<\/jats:p>","DOI":"10.1097\/crd.0000000000000902","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:30:59Z","timestamp":1743517859000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Cardiovascular Manifestations in Transgender Individuals"],"prefix":"10.1097","author":[{"given":"Azin","family":"Karimian","sequence":"first","affiliation":[{"name":"From theCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Shokri","sequence":"additional","affiliation":[{"name":"From theCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Valley Health System, Las Vegas, NV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"},{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"R1-20250401","doi-asserted-by":"crossref","first-page":"e2022059680","DOI":"10.1542\/peds.2022-059680B","article-title":"Sex assigned at birth ratio among transgender and gender diverse adolescents in the United States.","volume":"150","author":"Turban","year":"2022","journal-title":"Pediatrics"},{"key":"R2-20250401","article-title":"Comparing two-step approaches to measuring gender identity: the reliability and applications of asking about sex assigned at birth versus transgender self-identification.","volume":"341","author":"Tordoff","year":"2024","journal-title":"Am J Epidemiol"},{"key":"R3-20250401","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djab028","article-title":"Cancer stage, treatment, and survival among transgender patients in the United States.","volume":"113","author":"Jackson","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"R4-20250401","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/brainsci12030366","article-title":"Substance use in the transgender population: a meta-analysis.","volume":"12","author":"Cotaina","year":"2022","journal-title":"Brain Sci"},{"key":"R5-20250401","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/09540261.2022.2093629","article-title":"Mental health in transgender individuals: a systematic review.","volume":"34","author":"Pinna","year":"2022","journal-title":"Int Rev Psychiatry"},{"key":"R6-20250401","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/lgbt.2016.0208","article-title":"Transgender medicare beneficiaries and chronic conditions: exploring fee-for-service claims data.","volume":"4","author":"Dragon","year":"2017","journal-title":"LGBT Health"},{"key":"R7-20250401","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jsxm.2016.02.001","article-title":"Prevalence of transgender depends on the \u201ccase\u201d definition: a systematic review.","volume":"13","author":"Collin","year":"2016","journal-title":"J Sex Med"},{"key":"R8-20250401","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review.","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"key":"R9-20250401","doi-asserted-by":"crossref","first-page":"e000499","DOI":"10.1136\/bmjmed-2023-000499","article-title":"Transgender identity in young people and adults recorded in UK primary care electronic patient records: retrospective, dynamic, cohort study.","volume":"2","author":"McKechnie","year":"2023","journal-title":"BMJ Med"},{"key":"R10-20250401","doi-asserted-by":"crossref","first-page":"e2418814","DOI":"10.1001\/jamanetworkopen.2024.18814","article-title":"Prevalence of gender-affirming surgical procedures among minors and adults in the US.","volume":"7","author":"Dai","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R11-20250401","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","article-title":"Cardiovascular disease in transgender people: a systematic review and meta-analysis.","volume":"190","author":"van Zijverden","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"R12-20250401","doi-asserted-by":"crossref","first-page":"e005597","DOI":"10.1161\/CIRCOUTCOMES.119.005597","article-title":"Cardiovascular disease risk factors and myocardial infarction in the transgender population.","volume":"12","author":"Alzahrani","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R13-20250401","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1161\/CIR.0000000000001003","article-title":"Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association.","volume":"144","author":"Streed","year":"2021","journal-title":"Circulation"},{"key":"R14-20250401","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12889-023-17537-z","article-title":"Physical and psychosocial challenges of people with gender dysphoria: a content analysis study.","volume":"24","author":"Ghiasi","year":"2024","journal-title":"BMC Public Health"},{"key":"R15-20250401","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jadohealth.2023.01.023","article-title":"Age of realization and disclosure of gender identity among transgender adults.","volume":"72","author":"Turban","year":"2023","journal-title":"J Adolesc Health"},{"key":"R16-20250401","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient.","volume":"171","author":"Safer","year":"2019","journal-title":"Ann Intern Med"},{"key":"R17-20250401","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s13178-021-00602-w","article-title":"Uncertainty and confusion regarding transgender non-discrimination policies: implications for the mental health of transgender Americans.","volume":"19","author":"Hughto","year":"2022","journal-title":"Sex Res Social Policy"},{"key":"R18-20250401","doi-asserted-by":"crossref","first-page":"e3937","DOI":"10.1210\/clinem\/dgac251","article-title":"Continuation of gender-affirming hormones among transgender adolescents and adults.","volume":"107","author":"Roberts","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20250401","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cen.13821","article-title":"Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration.","volume":"89","author":"Gava","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-20250401","doi-asserted-by":"crossref","first-page":"e53092","DOI":"10.2196\/53092","article-title":"Effectiveness and safety of different estradiol regimens in transgender women (TREAT Study): protocol for a randomized controlled trial.","volume":"12","author":"Cortez","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"R21-20250401","doi-asserted-by":"crossref","first-page":"e0261312","DOI":"10.1371\/journal.pone.0261312","article-title":"The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis.","volume":"17","author":"Schutte","year":"2022","journal-title":"PLoS One"},{"key":"R22-20250401","first-page":"385","article-title":"Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy.","volume":"66","author":"Aranda","year":"2019","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"R23-20250401","first-page":"991","article-title":"The prevalence of gender dysphoria in Scotland: a primary care study.","volume":"49","author":"Wilson","year":"1999","journal-title":"Br J Gen Pract"},{"key":"R24-20250401","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society.","volume":"388","author":"Winter","year":"2016","journal-title":"Lancet"},{"key":"R25-20250401","doi-asserted-by":"crossref","first-page":"100096","DOI":"10.1016\/j.focus.2023.100096","article-title":"Cardiovascular disease risk estimation for transgender and gender-diverse patients: cross-sectional analysis of baseline data from the LITE plus cohort study.","volume":"2","author":"Poteat","year":"2023","journal-title":"AJPM Focus"},{"key":"R26-20250401","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.obpill.2024.100125","article-title":"Prevalence of cardiovascular events among transgender adults with obesity: a population-based analysis.","volume":"11","author":"Pingili","year":"2024","journal-title":"Obes Pillars"},{"key":"R27-20250401","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jsxm.2021.04.006","article-title":"Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review.","volume":"18","author":"Kotamarti","year":"2021","journal-title":"J Sex Med"},{"key":"R28-20250401","doi-asserted-by":"crossref","first-page":"741866","DOI":"10.3389\/fendo.2021.741866","article-title":"Risk of venous thromboembolism in transgender people undergoing hormone feminizing therapy: a prevalence meta-analysis and meta-regression study.","volume":"12","author":"Totaro","year":"2021","journal-title":"Front Endocrinol"},{"key":"R29-20250401","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis.","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"R30-20250401","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eprac.2021.03.010","article-title":"Minimizing venous thromboembolism in feminizing hormone therapy: applying lessons from cisgender women and previous data.","volume":"27","author":"Zucker","year":"2021","journal-title":"Endocrine Pract"},{"key":"R31-20250401","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy: results from a large cohort study.","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"key":"R32-20250401","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1253\/circrep.CR-23-0021","article-title":"Cardiovascular risk in transgender people with gender-affirming hormone treatment.","volume":"5","author":"Masumori","year":"2023","journal-title":"Circ Rep"},{"key":"R33-20250401","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccm.2004.10.015","article-title":"Community-acquired pneumonia and sepsis.","volume":"26","author":"Beutz","year":"2005","journal-title":"Clin Chest Med"},{"key":"R34-20250401","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study.","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"R35-20250401","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"R36-20250401","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second-and third-generation oral contraceptives.","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"R37-20250401","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"R38-20250401","first-page":"237","article-title":"Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.","volume":"249","author":"Gotts\u00e4ter","year":"2001","journal-title":"J Intern Med"},{"key":"R39-20250401","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JBM.S166780","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.","volume":"10","author":"Goldstein","year":"2019","journal-title":"J Blood Med"},{"key":"R40-20250401","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/jc.2012-2030","article-title":"Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens.","volume":"97","author":"Seal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-20250401","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R42-20250401","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"key":"R43-20250401","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case\u2013control study.","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R44-20250401","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/EJE-19-0463","article-title":"Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.","volume":"182","author":"Meyer","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"R45-20250401","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study.","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"R47-20250401","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study.","volume":"159","author":"Tuckuviene","year":"2011","journal-title":"J Pediatr"},{"key":"R48-20250401","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.","volume":"139","author":"van Ommen","year":"2001","journal-title":"J Pediatr"},{"key":"R49-20250401","doi-asserted-by":"crossref","first-page":"895916","DOI":"10.3389\/fcvm.2022.895916","article-title":"Estrogen mediates an atherosclerotic-protective action via estrogen receptor Alpha\/SREBP-1 signaling.","volume":"9","author":"Xie","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R50-20250401","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5455\/dmm.20160929104837","article-title":"Activation of hepatic AMPK by 17beta-estradiol suppresses both nuclear receptor Nr2c2\/TR4 and its downstream lipogenic targets, reduces gluconeogenic genes and improves insulin signaling.","volume":"4","author":"AlQahtani","year":"2016","journal-title":"Dis Mol Med"},{"key":"R51-20250401","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00404-006-0187-2","article-title":"The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.","volume":"274","author":"Bayrak","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"R52-20250401","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1210\/en.2004-0228","article-title":"The low-density lipoprotein receptor is regulated by estrogen and forms a functional complex with the estrogen-regulated protein ezrin in pituitary GH3 somatolactotropes.","volume":"145","author":"Smith","year":"2004","journal-title":"Endocrinology"},{"key":"R53-20250401","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-20-0619","article-title":"Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.","volume":"183","author":"Marlatt","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"R54-20250401","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jsxm.2021.01.185","article-title":"Does gender-affirming hormonal treatment affect 30-year cardiovascular risk in transgender persons? A two-year prospective European study (ENIGI).","volume":"18","author":"Cocchetti","year":"2021","journal-title":"J Sex Med"},{"issue":"Supplement_1","key":"R55-20250401","doi-asserted-by":"crossref","first-page":"bvae163. 1714","DOI":"10.1210\/jendso\/bvae163.1714","article-title":"Long-term effects of gender affirming hormone therapy (GAHT) on lipid profile.","volume":"8","author":"Le","journal-title":"J Endocr Soc"},{"key":"R56-20250401","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"Supplement_1","key":"R57-20250401","doi-asserted-by":"crossref","first-page":"bvad114. 2071","DOI":"10.1210\/jendso\/bvad114.2071","article-title":"SAT400 evaluation of lipid profile of transgender women on long-term estrogen therapy.","volume":"7","author":"Mobilia Alvares","year":"2023","journal-title":"J Endocr Soc"},{"key":"R58-20250401","doi-asserted-by":"crossref","first-page":"101265","DOI":"10.1016\/j.jacadv.2024.101265","article-title":"Impact of gender-affirming hormonal therapy on cardiovascular risk factors in transgender health: an updated meta-analysis.","volume":"3","author":"Rahman","year":"2024","journal-title":"JACC Adv"},{"key":"R59-20250401","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/er.2001-0045","article-title":"Estrogen modulation of endothelial nitric oxide synthase.","volume":"23","author":"Chambliss","year":"2002","journal-title":"Endocr Rev"},{"key":"R60-20250401","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/092986709788186093","article-title":"Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.","volume":"16","author":"Smiley","year":"2009","journal-title":"Curr Med Chem"},{"key":"R61-20250401","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"key":"R62-20250401","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/HYPERTENSIONAHA.120.16839","article-title":"Blood pressure effects of gender-affirming hormone therapy in transgender and gender-diverse adults.","volume":"77","author":"Banks","year":"2021","journal-title":"Hypertension"},{"key":"R63-20250401","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen.","volume":"104","author":"Van Velzen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-20250401","doi-asserted-by":"crossref","first-page":"H340","DOI":"10.1152\/ajpheart.00151.2024","article-title":"Association between serum estradiol and cardiovascular health among transgender adults using gender-affirming estrogen therapy.","volume":"327","author":"Rytz","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl 3","key":"R65-20250401","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/01.hjh.0000941040.55163.0e","article-title":"Is there a dose of cyproterone acetate low enough to avoid hypertension development in young transgender women?","volume":"41","author":"Kuzior","year":"2023","journal-title":"J Hypertens"},{"key":"R66-20250401","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.trsl.2009.07.007","article-title":"Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients.","volume":"154","author":"Hu","year":"2009","journal-title":"Transl Res"},{"key":"R67-20250401","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1253\/circj.CJ-10-0941","article-title":"Gender and age differences in candidates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias.","volume":"75","author":"Tanaka","year":"2011","journal-title":"Circ J"},{"key":"R68-20250401","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/PL00005119","article-title":"Effects of 17\u03b2-estradiol on action potentials and ionic currents in male rat ventricular myocytes.","volume":"356","author":"Berger","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R69-20250401","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvac103","article-title":"Initiation of ventricular arrhythmia in the acquired long QT syndrome.","volume":"119","author":"Alexander","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R70-20250401","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/anec.12050","article-title":"Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval.","volume":"18","author":"Sedlak","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R71-20250401","doi-asserted-by":"crossref","first-page":"e0181875","DOI":"10.1371\/journal.pone.0181875","article-title":"GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization,\u201cGENEREPOL study\u201d: lack of common variants with large effect sizes.","volume":"12","author":"Salem","year":"2017","journal-title":"PLoS One"},{"key":"R72-20250401","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.lfs.2003.12.023","article-title":"Suppression by 17\u03b2-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors.","volume":"75","author":"Mori","year":"2004","journal-title":"Life Sci"},{"key":"R73-20250401","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4239\/wjd.v11.i3.66","article-title":"Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: a systematic review.","volume":"11","author":"Spanos","year":"2020","journal-title":"World J Diabetes"},{"key":"R74-20250401","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/dc19-1061","article-title":"Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people.","volume":"43","author":"Shadid","year":"2020","journal-title":"Diabetes Care"},{"key":"R75-20250401","doi-asserted-by":"crossref","first-page":"2042018820985681","DOI":"10.1177\/2042018820985681","article-title":"Insulin resistance in transgender individuals correlates with android fat mass.","volume":"12","author":"Bretherton","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"R76-20250401","doi-asserted-by":"crossref","first-page":"e2000","DOI":"10.1210\/clinem\/dgab934","article-title":"Incident diabetes risk is not increased in transgender individuals using hormone therapy.","volume":"107","author":"van Velzen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R77-20250401","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl_1","key":"R78-20250401","doi-asserted-by":"crossref","first-page":"A18991","DOI":"10.1161\/circ.148.suppl_1.18991","article-title":"Effect of sex steroids on lipid profile in female to male transgender patients: a systematic review and meta-analysis.","volume":"148","author":"Rahman","year":"2023","journal-title":"Circulation"},{"key":"R79-20250401","first-page":"100349","article-title":"Changes in blood lipids following initiation of gender affirming hormone therapy: a systematic review and meta-analysis.","volume":"36","author":"Gosiker","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"R80-20250401","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JRS-200087","article-title":"The metabolic effects of hormonal treatment in transgender males: safety of the testosterone gender-affirming therapy.","volume":"34","author":"Milionis","year":"2023","journal-title":"Int J Risk Saf Med"},{"key":"R81-20250401","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jtha.2024.05.015","article-title":"Thrombotic risk associated with gender-affirming hormone therapy.","volume":"22","author":"Mullins","year":"2024","journal-title":"J Thromb Haemost"},{"key":"R82-20250401","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point.","volume":"69","author":"Bachman","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R84-20250401","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/clinem\/dgab089","article-title":"Erythrocytosis in a large cohort of trans men using testosterone: a long-term follow-up study on prevalence, determinants, and exposure years.","volume":"106","author":"Madsen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R85-20250401","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1370\/afm.3018","article-title":"Erythrocytosis in gender-affirming care with testosterone.","volume":"21","author":"Porat","year":"2023","journal-title":"Ann Fam Med"},{"key":"R86-20250401","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2021.09.005","article-title":"Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.","volume":"207","author":"Oakes","year":"2021","journal-title":"Thromb Res"},{"key":"R87-20250401","doi-asserted-by":"crossref","first-page":"e2020023549","DOI":"10.1542\/peds.2020-023549","article-title":"Thrombosis risk in transgender adolescents receiving gender-affirming hormone therapy.","volume":"147","author":"Mullins","year":"2021","journal-title":"Pediatrics"},{"key":"R88-20250401","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2024.02.029","article-title":"Effects of gender affirming hormone therapy with testosterone on coagulation and hematological parameters in transgender people assigned female at birth: a systematic review and meta-analysis.","volume":"236","author":"Tienforti","year":"2024","journal-title":"Thromb Res"},{"key":"R89-20250401","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2017.05.008","article-title":"Stigma and diurnal cortisol among transitioning transgender men.","volume":"82","author":"DuBois","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"R90-20250401","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/andr.12392","article-title":"Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial.","volume":"5","author":"Gagliano-Juc\u00e1","year":"2017","journal-title":"Andrology"},{"key":"R91-20250401","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/HJH.0000000000000029","article-title":"Higher blood hematocrit predicts hypertension in men.","volume":"32","author":"Jae","year":"2014","journal-title":"J Hypertens"},{"key":"R92-20250401","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2017.08.014","article-title":"Exogenous testosterone enhances cortisol and affective responses to social-evaluative stress in dominant men.","volume":"85","author":"Knight","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"7_Pt_2","key":"R93-20250401","doi-asserted-by":"crossref","first-page":"260S","DOI":"10.1093\/ajh\/6.7.260S","article-title":"Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis.","volume":"6","author":"Sowers","year":"1993","journal-title":"Am J Hypertens"},{"key":"R94-20250401","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11154-018-9454-3","article-title":"Cardiovascular health in transgender people.","volume":"19","author":"Irwig","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"R95-20250401","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/01.hjh.0000837524.32962.96","article-title":"Does gender-affirming hormonal therapy cause a significant rise of blood pressure in young transgender people?","volume":"40","author":"Kuzior","year":"2022","journal-title":"J Hypertens"},{"key":"R96-20250401","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/CIRCULATIONAHA.122.061010","article-title":"Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the western Denmark heart registry.","volume":"147","author":"Mortensen","year":"2023","journal-title":"Circulation"},{"key":"R97-20250401","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","article-title":"Endothelial protection by high-density lipoproteins: from bench to bedside.","volume":"23","author":"Calabresi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R98-20250401","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"R99-20250401","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-8703(96)90556-6","article-title":"Links between hypertension and myocardial infarction.","volume":"132","author":"Rakugi","year":"1996","journal-title":"Am Heart J"},{"key":"R100-20250401","doi-asserted-by":"crossref","first-page":"1289254","DOI":"10.3389\/fendo.2024.1289254","article-title":"Effect of mind-body exercise on risk factors for metabolic syndrome including insulin resistance: a meta-analysis.","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"R101-20250401","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/geroni\/igaa057.1270","article-title":"Chronic stress and risks for myocardial infarction in US adults.","volume":"4","author":"Farmer","year":"2020","journal-title":"Innov. Aging"},{"key":"R102-20250401","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10389-019-01172-3","article-title":"The impact of frequency, pattern, intensity, and type of alcohol consumption, and its combined effect with smoking on inflammation, lipid profile, and the risk of myocardial infarction.","volume":"29","author":"Attard","year":"2021","journal-title":"J Public Health"},{"key":"R103-20250401","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2016.03.029","article-title":"Obesity or smoking: which factor contributes more to the incidence of myocardial infarction?","volume":"32","author":"Dicker","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"sup1","key":"R104-20250401","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8.","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"23_suppl_1","key":"R106-20250401","doi-asserted-by":"crossref","first-page":"I-9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism.","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"R107-20250401","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/asj\/sjac091","article-title":"The effect of preoperative gender-affirming hormone therapy use on perioperative adverse events in transmasculine individuals undergoing masculinizing chest surgery for gender affirmation.","volume":"42","author":"Wu","year":"2022","journal-title":"Aesthet Surg J"},{"key":"R108-20250401","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/PRS.0000000000011437","article-title":"Perioperative estrogen hormonal therapy does not increase venous thromboembolism risk in facial feminization surgery.","volume":"154","author":"Li","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R111-20250401","doi-asserted-by":"crossref","first-page":"bvab011","DOI":"10.1210\/jendso\/bvab011","article-title":"Hormone therapy, mental health, and quality of life among transgender people: a systematic review.","volume":"5","author":"Baker","year":"2021","journal-title":"J Endocr Soc"},{"key":"R112-20250401","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jpepsy\/jsaa040","article-title":"Health disparities in transgender and gender expansive adolescents: a topical review from a minority stress framework.","volume":"45","author":"Delozier","year":"2020","journal-title":"J Pediatr Psychol"},{"key":"R113-20250401","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1161\/CIR.0000000000000914","article-title":"Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association.","volume":"142","author":"Caceres","year":"2020","journal-title":"Circulation"},{"key":"R114-20250401","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10865-019-00102-8","article-title":"Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014-2017 BRFSS.","volume":"43","author":"Caceres","year":"2020","journal-title":"J Behav Med"},{"key":"R115-20250401","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/trgh.2019.0074","article-title":"Stigma, resilience, and health care use among transgender and other gender diverse youth in the United States.","volume":"5","author":"Goldenberg","year":"2020","journal-title":"Transgend Health"},{"key":"R116-20250401","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response.","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"key":"R117-20250401","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","article-title":"Cardiovascular consequences of cortisol excess.","volume":"1","author":"Whitworth","year":"2005","journal-title":"Vasc Health Risk Manag"},{"key":"R118-20250401","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1016\/j.neuron.2022.10.017","article-title":"The sympathetic nervous system in the 21st century: neuroimmune interactions in metabolic homeostasis and obesity.","volume":"110","author":"Martinez-Sanchez","year":"2022","journal-title":"Neuron"},{"key":"R119-20250401","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11906-015-0594-5","article-title":"Role of the sympathetic nervous system in stress-mediated cardiovascular disease.","volume":"17","author":"Hering","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"R120-20250401","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/hm.HM-D-24-00040","article-title":"Impact of chronic psychological stress on cardiovascular disease risk: a narrative review.","volume":"8","author":"Munir","year":"2024","journal-title":"Heart and Mind"},{"key":"R121-20250401","doi-asserted-by":"crossref","first-page":"599341","DOI":"10.3389\/fcvm.2021.599341","article-title":"Chronic stress-related neural activity associates with subclinical cardiovascular disease in a community-based cohort: data from the Washington, D.C. Cardiovascular Health and Needs Assessment.","volume":"8","author":"Powell-Wiley","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R122-20250401","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2021.02.031","article-title":"Assessment of cardiovascular risk in transgender patients presenting for gender-affirming care.","volume":"134","author":"Denby","year":"2021","journal-title":"Am J Med"},{"key":"R123-20250401","doi-asserted-by":"crossref","first-page":"100146","DOI":"10.1016\/j.ynstr.2018.100146","article-title":"Stress and substance use among sexual and gender minority individuals across the lifespan.","volume":"10","author":"Parent","year":"2019","journal-title":"Neurobiol Stress"},{"key":"R124-20250401","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.2105\/AJPH.2010.197285","article-title":"Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work.","volume":"101","author":"Nemoto","year":"2011","journal-title":"Am J Public Health"},{"key":"R125-20250401","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2105\/AJPH.2013.301545","article-title":"Gender abuse and major depression among transgender women: a prospective study of vulnerability and resilience.","volume":"104","author":"Nuttbrock","year":"2014","journal-title":"Am J Public Health"},{"key":"R126-20250401","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0959353509342771","article-title":"Transgender people in Australia and New Zealand: health, well-being and access to health services.","volume":"19","author":"Pitts","year":"2009","journal-title":"Feminism Psychol"},{"key":"R127-20250401","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2105\/AJPH.2013.301241","article-title":"Stigma, mental health, and resilience in an online sample of the US transgender population.","volume":"103","author":"Bockting","year":"2013","journal-title":"Am J Public Health"},{"key":"R128-20250401","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/19359705.2016.1228553","article-title":"Perception of community tolerance and prevalence of depression among transgender persons.","volume":"21","author":"Owen-Smith","year":"2017","journal-title":"J Gay Lesbian Ment Health"},{"key":"R129-20250401","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1037\/a0031774","article-title":"Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping.","volume":"81","author":"Budge","year":"2013","journal-title":"J Consult Clin Psychol"},{"key":"R130-20250401","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/09540121.2013.855701","article-title":"Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center.","volume":"26","author":"Reisner","year":"2014","journal-title":"AIDS Care"},{"key":"R131-20250401","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jad.2020.05.074","article-title":"Increased prevalence of depression, anxiety, and adjustment and somatoform disorders in transsexual individuals.","volume":"274","author":"Konrad","year":"2020","journal-title":"J Affect Disord"},{"key":"R132-20250401","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/10826084.2017.1418087","article-title":"Mental health correlates of cigarette use in LGBT individuals in the Southeastern United States.","volume":"53","author":"Drescher","year":"2018","journal-title":"Subst Use Misuse"},{"key":"R133-20250401","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s11136-024-03664-6","article-title":"The effects of gender-affirming hormone therapy and mastectomy on psychopathology, body image, and quality of life in adults with gender dysphoria who were assigned female at birth.","volume":"33","author":"Turan","year":"2024","journal-title":"Qual Life Res"},{"key":"R134-20250401","doi-asserted-by":"crossref","first-page":"e220978","DOI":"10.1001\/jamanetworkopen.2022.0978","article-title":"Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care.","volume":"5","author":"Tordoff","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R135-20250401","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/PRS.0000000000011325","article-title":"Gender-affirming surgery improves mental health outcomes and decreases antidepressant use in patients with gender dysphoria.","volume":"154","author":"Kilmer","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R136-20250401","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/lgbt.2015.0124","article-title":"Differences in healthcare access, use, and experiences within a community sample of racially diverse lesbian, gay, bisexual, transgender, and questioning emerging adults.","volume":"3","author":"Macapagal","year":"2016","journal-title":"LGBT Health"},{"key":"R137-20250401","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to healthcare for transgender individuals.","volume":"23","author":"Safer","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R138-20250401","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2105\/AJPH.2007.132035","article-title":"Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City.","volume":"99","author":"Sanchez","year":"2009","journal-title":"Am J Public Health"},{"key":"R139-20250401","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4158\/EP.14.2.248","article-title":"Out of the shadows: it is time to mainstream treatment for transgender patients.","volume":"14","author":"Safer","year":"2008","journal-title":"Endocr Pract"},{"key":"R140-20250401","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s44263-024-00073-2","article-title":"Healthcare access and barriers to utilization among transgender and gender diverse people in Africa: a systematic review.","volume":"2","author":"Jessani","year":"2024","journal-title":"BMC Glob Public Health"},{"key":"R141-20250401","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/CIRCULATIONAHA.110.968743","article-title":"Public policy approaches to the prevention of heart disease and stroke.","volume":"124","author":"Pearson","year":"2011","journal-title":"Circulation"},{"key":"R142-20250401","article-title":"Gender incongruence and transgender health in the ICD.","year":"2025"},{"key":"R143-20250401","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2019.19010080","article-title":"Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study.","volume":"177","author":"Br\u00e4nstr\u00f6m","year":"2020","journal-title":"Am J Psychiatry"},{"key":"R144-20250401","doi-asserted-by":"crossref","first-page":"104047","DOI":"10.1016\/j.ijnurstu.2021.104047","article-title":"Trans-affirming care: an integrative review and concept analysis.","volume":"123","author":"Lightfoot","year":"2021","journal-title":"Int J Nurs Stud"},{"key":"R145-20250401","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/sres.932","article-title":"Learning behaviours in the workplace: the role of high-quality interpersonal relationships and psychological safety.","volume":"26","author":"Carmeli","year":"2009","journal-title":"Syst Res Behav Sci"},{"key":"R146-20250401","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/medu.13796","article-title":"Transphobia rather than education predicts provider knowledge of transgender health care.","volume":"53","author":"Stroumsa","year":"2019","journal-title":"Med Educ"},{"key":"R147-20250401","doi-asserted-by":"crossref","first-page":"ckad160.756","DOI":"10.1093\/eurpub\/ckad160.756","article-title":"A first intervention to support the mental health of transgender individuals in Eastern Europe.","volume":"33","author":"Lelutiu-Weinberger","year":"2023","journal-title":"Eur J Public Health"},{"key":"R148-20250401","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11524-015-0011-z","article-title":"LifeSkills for men (LS4M): pilot evaluation of a gender-affirmative HIV and STI prevention intervention for young adult transgender men who have sex with men.","volume":"93","author":"Reisner","year":"2016","journal-title":"J Urban Health"},{"key":"R149-20250401","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/pro0000154","article-title":"An AFFIRMative cognitive behavioral intervention for transgender youth: preliminary effectiveness.","volume":"49","author":"Austin","year":"2018","journal-title":"Prof Psychol Res Pract"},{"key":"R150-20250401","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic impact goal through 2020 and beyond.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"R151-20250401","doi-asserted-by":"crossref","first-page":"e0297571","DOI":"10.1371\/journal.pone.0297571","article-title":"Physical activity among transgender individuals: a systematic review of quantitative and qualitative studies.","volume":"19","author":"Lightner","year":"2024","journal-title":"PLoS One"},{"key":"R152-20250401","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.3390\/nu16183139","article-title":"Dietary habits, physical activity and body mass index in transgender and gender diverse adults in Italy: a voluntary sampling observational study.","volume":"16","author":"Santangelo","year":"2024","journal-title":"Nutrients"},{"key":"R153-20250401","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jadohealth.2019.10.026","article-title":"Diet and physical activity behaviors among adolescent transgender students: school survey results.","volume":"66","author":"Bishop","year":"2020","journal-title":"J Adolesc Health"},{"key":"R154-20250401","doi-asserted-by":"crossref","DOI":"10.1111\/and.12660","article-title":"Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis.","volume":"49","author":"Klaver","year":"2017","journal-title":"Andrologia"},{"key":"R155-20250401","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"R156-20250401","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/lgbt.2018.0103","article-title":"The relationship between tobacco use and legal document gender-marker change, hormone use, and gender-affirming surgery in a united states sample of trans-feminine and trans-masculine individuals: implications for cardiovascular health.","volume":"5","author":"Kidd","year":"2018","journal-title":"LGBT Health"},{"key":"R157-20250401","doi-asserted-by":"crossref","first-page":"e27417","DOI":"10.2196\/27417","article-title":"Smoking protective and risk factors among transgender and gender-expansive individuals (Project SPRING): qualitative study using digital photovoice.","volume":"7","author":"Tan","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"R158-20250401","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R159-20250401","doi-asserted-by":"crossref","first-page":"e1001515","DOI":"10.1371\/journal.pmed.1001515","article-title":"Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.","volume":"10","author":"Cheng","year":"2013","journal-title":"PLoS Med"},{"key":"R160-20250401","doi-asserted-by":"crossref","first-page":"e0168878","DOI":"10.1371\/journal.pone.0168878","article-title":"Weight change and risk of venous thromboembolism: the Troms\u00f8 Study.","volume":"11","author":"Horvei","year":"2016","journal-title":"PLoS One"},{"key":"R161-20250401","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JBM.S166780","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.","volume":"10","author":"Goldstein","year":"2019","journal-title":"J Blood Med"},{"key":"R162-20250401","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"R163-20250401","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/MPH.0000000000000984","article-title":"Hormone therapy and venous thromboembolism in a transgender adolescent.","volume":"40","author":"Stanley","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R164-20250401","doi-asserted-by":"crossref","first-page":"E502","DOI":"10.1503\/cmaj.160408","article-title":"Deep vein thrombosis in a transgender woman.","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ"},{"key":"R165-20250401","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline.","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"key":"R166-20250401","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13685530802389628","article-title":"ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.","volume":"12","author":"Wang","year":"2009","journal-title":"Aging Male"},{"key":"R167-20250401","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO).","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"R168-20250401","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men.","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R169-20250401","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacl.2022.11.010","article-title":"Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy.","volume":"17","author":"Leemaqz","year":"2023","journal-title":"J Clin Lipidol"},{"key":"R170-20250401","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline.","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R171-20250401","doi-asserted-by":"crossref","first-page":"e031004","DOI":"10.1161\/JAHA.123.031004","article-title":"Considerations for gender-affirming hormonal and surgical care among transgender and gender diverse adolescents and adults with congenital heart disease.","volume":"13","author":"Harrison","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R172-20250401","doi-asserted-by":"crossref","first-page":"102197","DOI":"10.1016\/j.rpth.2023.102197","article-title":"Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays.","volume":"7","author":"Bouck","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"R173-20250401","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jth.14626","article-title":"Transgender patients and the role of the coagulation clinician.","volume":"17","author":"Connors","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R174-20250401","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults.","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:19:22Z","timestamp":1785856762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":169,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000902","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}